Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Clinical trial NCT04375813 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04375813
- Sponsor
- Robert Svatek
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2027-01-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.